drugset / Trial / NCT05206578

Study to Evaluate the Efficacy and Safety in Patients With Primary Hypercholesterolemia

NCT05206578 ↗

Phase 3 Unknown 264 enrolled Ahn-Gook Pharmaceuticals Co.,Ltd
RandomizedFactorialQuadruple-blindTreatment

Summary

To Evaluate the Efficacy and Safety of Combination Therapy of AGT and AGZ Versus Monotherapy of AGT in Patients With Primary Hypercholesterolemia.

Timeline

Start
2020-12-08
Primary completion
2022-07-07
Completion
2022-09-08

Drugs

EvaluationDrugModalityDoseRoute
Subject AGT2 Unknown — —
Subject AGT4 Unknown — —
Subject AGZ Unknown — —

Indications